Association between lowered endothelial function measured by peripheral arterial tonometry and cardio-metabolic risk factors - a cross-sectional study of Finnish municipal workers at risk of diabetes and cardiovascular disease by Konttinen, Jussi et al.
Konttinen et al. BMC Cardiovascular Disorders 2013, 13:83
http://www.biomedcentral.com/1471-2261/13/83RESEARCH ARTICLE Open AccessAssociation between lowered endothelial function
measured by peripheral arterial tonometry and
cardio-metabolic risk factors – a cross-sectional
study of Finnish municipal workers at risk of
diabetes and cardiovascular disease
Jussi Konttinen1*, Harri Lindholm1, Juha Sinisalo2, Eeva Kuosma1, Janne Halonen1, Leila Hopsu1 and Jukka Uitti3Abstract
Background: The aim of this cross-sectional study was to determine the association between lowered endothelial
function measured by peripheral arterial tonometry (PAT) and cardio-metabolic risk factors. The study population
consisted of Finnish municipal workers who were at risk of diabetes or cardiovascular disease and who had
expressed a need to change their health behaviour.
Methods: A total of 312 middle-aged municipal workers underwent a physical medical examination and
anthropometry measurements. Levels of total cholesterol, HDL cholesterol, triglycerides, fasting glucose, glycated
haemoglobin, and high sensitivity C-reactive protein were taken from the blood samples. PAT measured the
increase in digital pulse volume amplitude during reactive hyperemia, and the index of endothelial function, F-RHI,
was defined as the ratio of post-deflation amplitude to baseline amplitude.
Results: In the linear regression model, male sex was associated with lower F-RHI. In sex-adjusted linear regression
models, each of the variables; waist circumference, fasting glucose, glycated hemoglobin, triglycerides, body fat
percentage, body mass index, current smoking, and impaired fasting glucose or diabetes were separately associated
with lower F-RHI, and HDL cholesterol and resting heart rate were associated with higher F-RHI.
HDL cholesterol, sex, body mass index, and current smoking entered a stepwise multivariable regression model, in
which HDL cholesterol was associated with higher F-RHI, and smoking, male sex and body mass index were
associated with lower F-RHI. This model explains 28.3% of the variability in F-RHI.
Conclusions: F-RHI is associated with several cardio-metabolic risk factors; low level of HDL cholesterol, male sex,
overweight and smoking being the most important predictors of a lowered endothelial function. A large part of
variation in F-RHI remains accounted for by unknown factors.
Keywords: Cardiovascular risk, Endothelial dysfunction, Peripheral arterial tonometry, Occupational health care* Correspondence: jussi.konttinen@ttl.fi
1Finnish Institute of Occupational Health, Topeliuksenkatu 41 a, A, FI-00250
Helsinki, Finland
Full list of author information is available at the end of the article
© 2013 Konttinen et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Konttinen et al. BMC Cardiovascular Disorders 2013, 13:83 Page 2 of 7
http://www.biomedcentral.com/1471-2261/13/83Background
The assessment of traditional risk factors is a basic elem-
ent in the primary prevention of cardiovascular disease
(CVD). New markers of increased risk or pre-symptomatic
disease are being studied in order to refine risk assessment
and to target the treatment of those at highest risk [1]. The
vascular endothelium plays a central role in the pathogen-
esis of CVD [2]. The measurements of endothelial function
are promising indicators of vascular health [2].
The term “endothelial dysfunction” refers to a broad
alteration in endothelial phenotype and capacity to main-
tain vascular homeostasis [2,3]. Endothelial dysfunction
contributes to the initiation and progression of athero-
sclerotic disease and is an individual cardiovascular risk
factor with prognostic value [2,3]. Many interventions that
reverse endothelial dysfunction also reduce cardiovascular
risk, and one potential use for the measurements of endo-
thelial function is the evaluation of interventions to reduce
CVD risk [2].
The most commonly used method to assess endothe-
lial function is to measure endothelium-dependent vaso-
dilatation by using stimuli that increase the production
of endothelium-derived nitric oxide [2]. The flow-mediated
dilatation in the brachial artery can be measured by vas-
cular ultrasound [4]. Peripheral arterial tonometry (PAT)
is a novel method for evaluating endothelial function. It
has been used in ambulatory settings and in large scale
trials [5,6]. PAT measures the increase in digital pulse
volume amplitude during reactive hyperemia in relation
to baseline. This response is reproducible, and has shown
to be mainly dependent on nitric oxide [7,8]. The re-
sponse is attenuated and the PAT score is lower in pa-
tients with coronary endothelial dysfunction [9]. There
is also a significant relationship between PAT measures
and brachial artery ultrasound measures [10]. Endothelial
dysfunction measured by PAT is associated with mul-
tiple cardiovascular risk factors [5,10-13]. The changes in
PAT-related endothelial function are reversible through
effective interventions [14-16], and may be useful for the
identification of patients at risk of cardiovascular adverse
events [17].
This cross-sectional study aims to investigate the asso-
ciation between the index of endothelial function mea-
sured by PAT, F-RHI (Framingham reactive hyperemia
index), and heterogenous cardio-metabolic risk factors
in a population of asymptomatic municipal workers.
Methods
Study design
This study is part of the larger Nuadu interventional
study, which aimed to create new methods of early rec-
ognition of people at health risks and a multi-factorial
lifestyle intervention suitable for occupational health care
[18]. Study subjects were selected from among municipalworkers (n = ~10900) in the City of Espoo, based on a
health questionnaire. A total of 4134 (38%) replied. The
questionnaire included items on physical activity, sleep,
smoking, drinking, nutrition, physical and mental stress
and strain, perceived health, and work ability. The inclu-
sion criteria were willingness to participate in the interven-
tion, age between 30–55 years, and a subjectively estimated
work ability of 7–9 on a scale of 0–10, 10 being lifetime
best [19]. Another important criterion was the willingness
to change health behaviour in one or more of the fol-
lowing target areas within the next six months: weight
control, physical activity, alcohol consumption, eating
habits, smoking or sleeping habits. Subjects also had to
have an increased diabetes risk on the basis of a question-
naire (12–20 points in the Diabetes risk test) [20] or at
least two of the following risk factors: body mass index
(BMI) 27–34.9, low physical activity level [21], sleep
deprivation (difference between self-estimated need of
sleep and actual sleeping time greater than two hours),
risky alcohol consumption based on AUDIT-C [22,23],
smoking, not eating vegetables daily and/or not eating dur-
ing the working day. Pregnant women were excluded from
the study. Among the respondents, 783 (19%) employees
fulfilled the inclusion criteria. Of these, 352 were randomly
selected for the intervention study. Seventeen people who
had a BMI of 35 or higher were excluded.
Participants of the intervention study answered the
basic Nuadu intervention questionnaire, underwent the
baseline measurements of the intervention, and received
personal feedback on their situation. Two randomised
groups participated in health behaviour interventions
and one served as the control. The questionnaires and
measurements were repeated one year later. The results
presented here are those of the baseline measurements.
Due to this, two intervention groups and a control
group were pooled in this article.
All subjects gave informed consent and the study
protocol was approved by the Coordinating Ethics Com-
mittee of the Hospital District of Helsinki and Uusimaa.
Physiological measurements
Every participant underwent a medical physical examin-
ation before the physiological measurements. We mea-
sured height, weight and waist circumference (WC).
Body composition was analysed by eight-polar bioelec-
trical impedance (BIA) (Body 3.0, Biospace Company Ltd,
Seoul, South Korea). The blood samples were analysed
according to the standard methods of the laboratory
of Helsinki University Central Hospital (Accredited la-
boratory, www.huslab.fi). They included total cholesterol,
HDL cholesterol, triglycerides, fasting glucose, glycated
hemoglobin (HbA1c) and high sensitivity C-reactive pro-
tein (hs-CRP). LDL cholesterol was estimated using the
Friedewald equation [24].
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Dichotomous risk factors were coded as 0 = absence of
risk factor, and 1 = presence of risk factor. The criteria
for coding the presence of risk factors were as follows:
1. Current smoking based on the intervention question-
naire; regular smoker, or casual smoker who was a regular
smoker in the earlier health questionnaire; 2. Family his-
tory of cardiovascular disease: myocardial infarction, cor-
onary revascularization, or sudden death of father or other
male first degree relative before 55 years of age, or mother
or other female first degree relative before 65 years of
age; 3. Hypertension treatment or lipid lowering treat-
ment: medication used regularly or often; 4. Impaired
fasting glucose or diabetes: in laboratory measurements
a fasting glucose of ≥ 6.1 mmol/l; 5. Hypertension: sys-
tolic blood pressure of ≥ 140 mm Hg and/or diastolic
blood pressure of ≥ 90 mm Hg; 6. Dyslipidemia: an LDL
cholesterol of < 3 mmol/l, triglycerides of > 2, an HDL
cholesterol of < 1 mmol/l and/or a total to HDL ratio
of > 4. In regression models, male sex was also considered
a risk factor.
Measurements of endothelial function
We measured the endothelial function of 312 partici-
pants. Digital pulse volume amplitude was measured and
analysed using the PAT method (Endo-PAT2000, Soft-
ware version 3.0.3, Itamar Medical Ltd, Caesarea, Israel).
The principle of PAT has been described earlier [10].
During the assessment, the participant was in a supine
position in a comfortable, quiet, and thermoneutral en-
vironment, with the lights dimmed.
Pneumatic probes were placed on the index finger
of each hand, and a blood pressure cuff was placed
on the left upper arm. The left hand underwent reactive
hyperemia testing and the contralateral hand served as the
control. The participants were allowed to lie down for a
couple of minutes before the recording of the pulsatile
volume changes began. After five minutes of baseline
measurement, the blood pressure cuff was rapidly inflated
to 200 mm Hg or 60 mm Hg above systolic blood pres-
sure, whichever was higher. Occlusion lasted for exactly
five minutes, after which the blood pressure cuff was de-
flated to induce reactive hyperemia. We continued record-
ing for five more minutes.
The PAT data was analysed by a computerised operator
independent algorithm with Endo-PAT2000 software. The
manufacturer’s basic index of vascular reactivity, RHI, is
defined as the ratio of postdeflation pulse amplitude to the
baseline pulse amplitude. The average amplitude of a one-
minute period of PAT signal, starting one minute after cuff
deflation, is divided by the average amplitude of the 2.5-
minute period of PAT baseline signal before cuff inflation.
This ratio is normalized to the corresponding ratio from
the control arm to compensate for potential systemicchanges in the amplitude. The automatic calculation of
RHI has an imbedded correction factor to deal with the
strong negative correlation between the baseline pulse
amplitude and the relative response. Baseline pulse ampli-
tude itself correlates with many cardiovascular risk factors,
and the correction factor may actually hide some relevant
information. Thus in this study, in addition to RHI, we
calculated and used an index without the correlation fac-
tor. F-RHI was defined as F-RHI = ln(RHo/RHc), where
RHo and RHc are the mean pulse amplitudes of the period
1.5–2 minutes after cuff deflation divided by mean base-
line amplitudes in the occluded arm and control arm, re-
spectively [11]. F-RHI is more highly associated with
cardiovascular risk factors and has also shown to be more
reproducible than RHI in adolescents [7].
Statistical methods
A linear regression model was used to determine the asso-
ciation of F-RHI with sex. We used twenty separate sex-
adjusted linear regression models to find the association of
F-RHI with each of the following cardiovascular and meta-
bolic risk factors: age, BMI, WC, body fat percentage
assessed by BIA, total cholesterol, HDL cholesterol, LDL
cholesterol, triglycerides, fasting glucose, HbA1c, hs-CRP,
systolic and diastolic blood pressure, resting heart rate,
rate-pressure product, hypertension treatment, lipid lower-
ing treatment, impaired fasting glucose or diabetes, family
history of CVD, and current smoking.
The normality of the variables was tested using
the Kolmogorov-Smirnov test. CRP values were log-
transformed for the regression models to obtain normal
distribution.
We selected the variables that were allowed to enter
the multivariable regression model in advance to avoid
co-linearity. As regards possible co-linear variables, we
selected the potential covariate based on current know-
ledge on the importance of the risk factors and the reliabil-
ity of the method used to measure it. In the multivariable
regression model we used a stepwise method for variable
selection. The criteria for entering or keeping the variable
in the model were p < 0.05 and p < 0.1, respectively. All
analyses were performed using SPSS 15.0 for Windows
(SPSS Inc., Chicago, IL, USA).
Results
Subject characteristics
Subject characteristics are presented in Tables 1 and 2.
Associations of F-RHI with cardiometabolic risk factors
Male sex was associated with lower F-RHI in the separ-
ate linear regression model.
Separate sex-adjusted linear regression models were used
to find the association of F-RHI with each of the other risk
factors. In these models WC, fasting glucose, glycated
Table 1 Subject characteristics tabulated by sex
Cardiovascular and metabolic
risk factors
Women
(n = 254)
Men
(n = 58)
p
Age (y) 44.6 ± 6.7 43.5 ± 7.6 0.278
Body mass index (kg/m2) 27.2 ± 4.1 27.6 ± 3.6 0.406
Waist circumference (cm) 90.4 ± 11.3 100.0 ± 10.1 <0.0001
Body fat percentage (%) 31.6 ± 6.6 22.2 ± 6.0 <0.0001
Total cholesterol (mmol/l) 4.7 ± 0.8 5.0 ± 1.0 0.039
HDL cholesterol (mmol/l) 1.6 ± 0.4 1.3 ± 0.3 <0.0001
LDL cholesterol (mmol/l) 2.6 ± 0.7 3.1 ± 0.9 <0.001
Triglycerides (mmol/l) 1.0 ± 0.6 1.4 ± 0.7 <0.001
Fasting glucose (mmol/l) 5.4 ± 0.8 5.5 ± 0.6 0.226
Glycated hemoglobin (%) 5.5 ± 0.4 5.6 ± 0.3 0.264
High sensitivity C-reactive protein
(mg/l)
2.11 ± 3.97 1.96 ± 3.08 0.912
Systolic blood pressure (mm Hg) 121 ± 13 125 ± 14 0.015
Diastolic blood pressure (mm Hg) 79 ± 8 81 ± 9 0.041
Resting heart rate (bpm) 69 ± 10 69 ± 11 0.619
Rate-pressure product 84 ± 16 86 ± 18 0.327
Framingham Reactive Hyperemia
Index
0.676 ± 0.401 0.325 ± 0.293 <0.0001
Reactive Hyperemia Index 2.272 ± 0.617 1.903 ± 0.403 <0.0001
Values are mean ± SD. P-value for differences of means between sexes.
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rent smoking, and impaired fasting glucose or diabetes
were inversely associated with F-RHI. The inverse relation-
ship between F-RHI and C-reactive protein was nearly sig-
nificant (p = 0.085). HDL cholesterol (Figure 1) and resting
heart rate were positively associated with F-RHI. No sig-
nificant relationships were found between F-RHI and age,
systolic or diastolic blood pressure, pulse pressure, rate-
pressure product, total cholesterol, LDL cholesterol, lipid
lowering treatment, hypertension treatment or family his-
tory of CVD. Table 3 shows the results.
For multivariable analysis, we selected the variables
that were allowed to enter the model in advance. Sex,Table 2 Risk factors and medication tabulated by sex
Cardiovascular and metabolic risk
factors
Women
(n = 254)
Men
(n = 58)
p
Current smoking 20.9 25.9 0.406
Body mass index > 25 65.4 81.0 0.021
Family history of cardiovascular disease 28.0 20.7 0.259
Impaired fasting glucose or diabetes 9.4 12.5 0.491
Hypertension treatment 11.0 5.2 0.179
Lipid lowering treatment 3.1 6.9 0.189
Hypertension 13.4 24.1 0.041
Dyslipidemia 31.1 67.9 <0.0001
Values are percentages, p-value for chi-square test.BMI, current smoking, fasting glucose, triglycerides, HDL
cholesterol, resting heart rate and C-reactive protein were
significantly or nearly significantly associated with F-RHI
in separate sex-adjusted models and were allowed to enter
the multivariable model. In addition, age, LDL cholesterol,
blood pressure and family history of CVD were allowed to
enter the model as strong risk factors for CVD or diabetes.
The variables selected by the stepwise procedure for the
final model from those listed above were HDL cholesterol,
sex, BMI and current smoking. This model explains 28.3%
of the variability in F-RHI. Table 4 shows the results.
Additional analysis
To further estimate if the risk factors play differently in
men and women we made separate multivariable models
for the two sexes. The variables that were selected for
the final model for women were HDL cholesterol, BMI
and smoking. The model explains 20.0% of the variability
in F-RHI. As regards men, only BMI entered the model,
which explains 13.8% of the variability. Tables 5 and 6
show the results.
Discussion
Several cardiovascular and metabolic risk factors were
associated with lowered endothelial function, measured
by the PAT method, among those at risk of diabetes and
cardiovascular disease. HDL cholesterol, current smok-
ing, sex and body mass index explain more than a fourth
of the variability in F-RHI.
As in previous studies, lower F-RHI was strongly asso-
ciated with male sex in the separate linear regression
model and the multivariable model [11,13]. Since vascu-
lar function and development of cardiovascular disease
differ between the sexes, it would be useful to study
men and women separately instead of using sex as a
covariate [25]. We performed additional analyses to find
possible sex differences in associations between F-RHI
and risk factors, but because of the low proportion of
male subjects, we were unable to build a reliable model
for men alone.
Lower F-RHI was strongly associated with obesity.
The strongest single association we found was between
F-RHI and BMI. Similar results can be obtained with
body fat percentage or WC. In separate sex-adjusted
models, all the inter-correlated measures of obesity; body
mass index, waist circumference and body fat percentage
measured by bioelectrical impedance analysis, were re-
lated to lower F-RHI. Of these, BMI was chosen as a can-
didate for the multivariable model and thus entered the
model. This observation was in accordance with earlier
studies [11,13].
Disturbed lipid profile associated with lower F-RHI.
In separate sex-adjusted models, high HDL cholesterol
was associated with higher F-RHI, and high triglycerides
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Figure 1 F-RHI and HDL cholesterol. F-RHI and HDL cholesterol values. Plot showing data points labelled separately for men and women and
fitted regression line adjusted for sex.
Table 3 Sex-adjusted associations of risk factors with F-RHI
Cardiovascular and metabolic
risk factors
Beta(se) p Partial
correlation
Sex −0.352(0.056) <0.0001 −0.337
Age −0.004(0.003) 0.185 −0.075
Body mass index −0.29(0.005) <0.0001 −0.304
Waist circumference −0.10(0.002) <0.0001 −0.280
Body fat percentage −0.011(0.003) <0.001 −0.194
Total cholesterol 0.011(0.025) 0.656 0.025
HDL cholesterol 0.310(0.056) <0.0001 0.302
LDL cholesterol −0.025(0.029) 0.390 −0.049
Triglycerides −0.123(0.035) <0.001 −0.197
Fasting glucose −0.100(0.029) <0.001 −0.193
Glycated hemoglobin −0.147(0.061) 0.017 −0.136
Log-transformed high sensitivity
C-reactive protein
−0.024(0.014) 0.085 −0.100
Systolic blood pressure 0.00(0.002) 0.968 0.002
Diastolic blood pressure −0.001(0.003) 0.825 −0.013
Resting heart rate 0.005(0.002) 0.023 0.130
Rate-pressure product 0.002(0.001) 0.084 0.099
Hypertension treatment −0.073(0.073) 0.316 −0.057
Lipid lowering treatment −0.031(0.113) 0.786 −0.015
Impaired fasting glucose or
diabetes
−0.140(0.070) 0.047 0.113
Family history of cardiovascular
disease
0.004(0.049) 0.940 0.004
Smoking −0.152(0.052) 0.004 −0.164
Slope (standard error), p-value, partial correlation coefficient.
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multivariable model, and was one of the strongest pre-
dictors of F-RHI. However, there were no associations
between F-RHI and total cholesterol, LDL cholesterol,
or lipid-lowering treatment. The lipid values in the study
population were better than those of the Finnish working
age population in general [26]. One study with dominantly
male subjects found a significant association between LDL
cholesterol and lower PAT score, but none with HDL
cholesterol, triglycerides or hyperlipidemia treatment [13].
Hamburg et al. found significant associations between
lower F-RHI and total/HDL cholesterol, triglycerides and
lipid-lowering treatment [11].
The findings concerning diabetes, fasting glucose and
current smoking also support earlier studies [11].
Inflammation plays an important role in the pathogen-
esis of atherosclerosis [27]. We found no significant as-
sociation between a marker of systemic inflammation,Table 4 Final stepwise multivariable regression model
Cardiovascular and metabolic
risk factors
Beta(se) p Partial
correlation
HDL cholesterol 0.240 (0.060) <0.0001 0.229
Sex −0.264 (0.057) <0.00001 −0.249
Body mass index −0.026 (0.006) <0.00001 −0.248
Smoking −0.154 (0.050) 0.0022 −0.157
1Model R2 0.283
Slope (standard error), p-value and partial correlation and 1square of multiple
correlation coefficient for model.
Table 5 Stepwise multivariable regression model for women
Cardiovascular and metabolic
risk factors
Beta(se) p Partial
correlation
HDL cholesterol 0.282 (0.064) <0.0001 0.273
Body mass index −0.024 (0.006) <0.001 −0.244
Smoking −0.157 (0.057) 0.007 −0.161
1Model R2 0.200
Slope (standard error), p-value, partial correlation and 1square of multiple
correlation coefficient for model.
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significant association between higher log-transformed
hs-CRP and lower F-RHI in the sex-adjusted model.
Age was not associated with F-RHI in the sex-adjusted
model or in the multivariable analysis. It is possible that
the range and distribution of age in our study population
was not sufficient to show a possible relation. Earlier
studies have shown a small but paradoxically positive as-
sociation between advancing age and higher F-RHI [11],
or no association at all between age and F-RHI [13].
Associations between F-RHI and blood pressure or
resting heart rate were modest and somewhat counterin-
tuitive. We found no association between F-RHI and sys-
tolic or diastolic blood pressure. Higher resting heart rate
was paradoxically associated with higher F-RHI in the sex-
adjusted model, although the beta coefficient was very
small. Truschel et al. [13] found a significant but counter-
intuitive positive association between F-RHI and systolic
blood pressure, but no relationship with resting heart rate
[13]. Hamburg et al., conversely found an association be-
tween lower F-RHI and higher heart rate [11].
Blood pressure values in our study population were
quite low compared to the Finnish working-age popula-
tion in general [26]. More hypertensive data might pos-
sibly provide better information on the association.
Although the result of the PAT measurement, F-RHI,
is mainly nitric oxide dependent, it is likely to be a com-
bination of macro- and micro-vascular reactivity and af-
fected by skin blood flow changes [28]. It is possible that
the hyperemic response in the fingertip microvessels dif-
fers from other vascular beds [11]. This study confirms
some of the associations found earlier between F-RHI and
certain risk factors. Many of the established cardio-
metabolic risk factors are associated with lower F-RHI asTable 6 Stepwise multivariable regression model for men
Cardiovascular and metabolic
risk factors
Beta(se) p Partial
correlation
Body mass index −0.031 (0.011) <0.007 −0.371
1Model R2 0.138
Slope (standard error), p-value, partial correlation and 1square of multiple
correlation coefficient for model.expected, but in this study the relationships with age,
blood pressure and heart rate in particular are not parallel
with the results of other studies, and need further
investigation.
The study’s strengths lie in the relatively large sample
size and a good coverage of municipal workers at inter-
mediate cardio-metabolic risk. We were also able to de-
termine a comprehensive set of risk factors and study
their associations with a novel measure of endothelial
function.
One limitation of this analysis is its cross-sectional de-
sign. In addition, the number of male subjects was low,
because the proportion of females among Finnish munici-
pal workers is commonly significantly higher. Measure-
ments of vascular reactivity were not carried out in a
fasting state due to the study design, although the subjects
were instructed to eat only lightly before the measure-
ments. A study using an ultrasound technique for measur-
ing endothelial function suggests that strict requirements
for fasting conditions may be unnecessary [29].
The menstrual cycle phase was not controlled for. The
women ranged from peri- to post-menopausal, but infor-
mation regarding hormonal status or the use of meno-
pausal hormones was not collected. In addition to sex,
hormonal status contributes to and modulates the devel-
opment of cardiovascular disease and should be taken in
to account in future study design [25].
The study sample consisted of Caucasian people of
European origin, thus the findings may not apply outside
this population.
Conclusions
In conclusion, the index of endothelial function, F-RHI,
measured by PAT is associated with several cardio-
metabolic risk factors; low HDL cholesterol level, male sex,
overweight and current smoking being the most important
predictors of a lowered F-RHI. A large part of the variation
in F-RHI is still explained by other factors, and relation-
ships between F-RHI and age or hemodynamic indices in
particular need further investigation.
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